Tristel (TSTL) Competitors

GBX 462.50
0.00 (0.00%)
(As of 05/3/2024 ET)

TSTL vs. BVC, AMS, OXB, BVXP, APH, HVO, BXP, AVCT, NIOX, and 4BB

Should you be buying Tristel stock or one of its competitors? The main competitors of Tristel include BATM Advanced Communications (BVC), Advanced Medical Solutions Group (AMS), Oxford Biomedica (OXB), Bioventix (BVXP), Alliance Pharma (APH), hVIVO (HVO), Beximco Pharmaceuticals (BXP), Avacta Group (AVCT), NIOX Group (NIOX), and 4basebio (4BB). These companies are all part of the "medical" sector.

Tristel vs.

Tristel (LON:TSTL) and BATM Advanced Communications (LON:BVC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

Tristel currently has a consensus price target of GBX 390, suggesting a potential downside of 15.68%. Given Tristel's higher probable upside, analysts clearly believe Tristel is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tristel
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Tristel's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Tristel Neutral
BATM Advanced Communications Neutral

Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 2.8%. BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.1%. Tristel pays out 10,833.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

50.2% of Tristel shares are owned by institutional investors. Comparatively, 41.8% of BATM Advanced Communications shares are owned by institutional investors. 5.3% of Tristel shares are owned by insiders. Comparatively, 26.2% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Tristel has a net margin of 15.29% compared to BATM Advanced Communications' net margin of -0.16%. Tristel's return on equity of 20.35% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Tristel15.29% 20.35% 9.89%
BATM Advanced Communications -0.16%-0.17%0.59%

BATM Advanced Communications received 42 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%

Tristel has a beta of 0.28, meaning that its share price is 72% less volatile than the S&P 500. Comparatively, BATM Advanced Communications has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500.

Tristel has higher earnings, but lower revenue than BATM Advanced Communications.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tristel£39.49M5.57£6.04M£0.123,854.17
BATM Advanced Communications£122.83M0.70£2.51MN/AN/A

Summary

Tristel beats BATM Advanced Communications on 10 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSTL vs. The Competition

MetricTristelMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£219.64M£3.18B£5.00B£1.73B
Dividend Yield2.84%1.89%2.89%5.95%
P/E Ratio3,854.17341.79176.652,116.59
Price / Sales5.57155.102,456.56454,847.26
Price / Cash20.96134.5849.7337.65
Price / Book7.013.104.882.51
Net Income£6.04M£94.50M£103.85M£182.50M
7 Day Performance-3.65%-0.05%3.93%0.99%
1 Month Performance-2.63%-3.43%-3.04%8.02%
1 Year Performance36.03%-6.34%4.24%14.97%

Tristel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
0 of 5 stars
GBX 18.65
-1.6%
N/A-22.2%£81.35M£122.83M2,800.00980
AMS
Advanced Medical Solutions Group
0 of 5 stars
GBX 190.40
+1.5%
GBX 300
+57.6%
-20.2%£413.82M£126.21M2,720.00800Positive News
OXB
Oxford Biomedica
1.1577 of 5 stars
GBX 220
+2.3%
GBX 498.75
+126.7%
-21.2%£219.91M£119.02M-343.75891Negative News
BVXP
Bioventix
0 of 5 stars
GBX 4,475
-1.1%
N/A+13.8%£233.60M£13.60M2,745.4012News Coverage
APH
Alliance Pharma
2.3671 of 5 stars
GBX 35.85
+1.0%
GBX 80.75
+125.2%
-49.8%£193.73M£170.05M-3,585.00285
HVO
hVIVO
0 of 5 stars
GBX 28.23
-0.1%
N/A+67.2%£192.03M£60.48M-1.00N/ANews Coverage
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 37
flat
N/A-9.6%£165.06M£41.65B462.505,700News Coverage
Gap Up
AVCT
Avacta Group
0 of 5 stars
GBX 44.51
+0.0%
N/A-60.1%£155.99M£16.02M-278.16120Gap Up
NIOX
NIOX Group
0.163 of 5 stars
GBX 66.80
+1.5%
GBX 77
+15.3%
+40.4%£282.40M£36.80M3,340.0092Gap Up
High Trading Volume
4BB
4basebio
0 of 5 stars
GBX 1,045
flat
N/A+70.1%£133.86M£311,000.00-2,049.0278Gap Up

Related Companies and Tools

This page (LON:TSTL) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners